Anita Giobbie-Hurder

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 23

Top Topics

Small Cell Lung Cancer

Metastatic Breast Cancer

Squamous Cell Carcinoma

Top Venues

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

NPJ breast cancer

Cancer research communications

Clinical cancer research : an official journal of the American Association for Cancer Research

This page only lists publications with an associated author ORCID identifier.

Publications

Elizabeth I Buchbinder, Justine V Cohen, Giuseppe Tarantino, Christine G Lian, David R Liu, Rizwan Haq, Frank Stephen Hodi, Donald P Lawrence, Anita Giobbie-Hurder, Deborah Knoerzer, Ryan J Sullivan
A Phase II Study of ERK Inhibition by Ulixertinib (BVD-523) in Metastatic Uveal Melanoma. Cancer research communications 4 (5) (2024)
Glenn J Hanna, Harita Dharanesswaran, Anita Giobbie-Hurder, John J Harran, Zixi Liao, Lori Pai, Vatche Tchekmedyian, Emily S Ruiz, Abigail H Waldman, Chrysalyne D Schmults, Leonardo V Riella, Patrick H Lizotte, Cloud P Paweletz, Anil K Chandraker, Naoka Murakami, Ann W Silk
Cemiplimab for Kidney Transplant Recipients With Advanced Cutaneous Squamous Cell Carcinoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (9) (2024)
Glenn J Hanna, Harita Dharanesswaran, Anita Giobbie-Hurder, John J Harran, Zixi Liao, Lori Pai, Vatche Tchekmedyian, Emily S Ruiz, Abigail H Waldman, Chrysalyne D Schmults, Leonardo V Riella, Patrick H Lizotte, Cloud P Paweletz, Anil K Chandraker, Naoka Murakami, Ann W Silk
Cemiplimab for Kidney Transplant Recipients With Advanced Cutaneous Squamous Cell Carcinoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Glenn J Hanna, Harita Dharanesswaran, Anita Giobbie-Hurder, John J Harran, Zixi Liao, Lori Pai, Vatche Tchekmedyian, Emily S Ruiz, Abigail H Waldman, Chrysalyne D Schmults, Leonardo V Riella, Patrick H Lizotte, Cloud P Paweletz, Anil K Chandraker, Naoka Murakami, Ann W Silk
Cemiplimab for Kidney Transplant Recipients With Advanced Cutaneous Squamous Cell Carcinoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (9) (2024)
Glenn J Hanna, Harita Dharanesswaran, Anita Giobbie-Hurder, John J Harran, Zixi Liao, Lori Pai, Vatche Tchekmedyian, Emily S Ruiz, Abigail H Waldman, Chrysalyne D Schmults, Leonardo V Riella, Patrick H Lizotte, Cloud P Paweletz, Anil K Chandraker, Naoka Murakami, Ann W Silk
Cemiplimab for Kidney Transplant Recipients With Advanced Cutaneous Squamous Cell Carcinoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (9) (2024)
Elizabeth I Buchbinder, Justine V Cohen, Giuseppe Tarantino, Christine G Lian, David R Liu, Rizwan Haq, Frank Stephen Hodi, Donald P Lawrence, Anita Giobbie-Hurder, Deborah Knoerzer, Ryan J Sullivan
A Phase II study of ERK inhibition by ulixertinib (BVD-523) in Metastatic Uveal Melanoma. Cancer research communications (2024)
Elizabeth I Buchbinder, Justine V Cohen, Giuseppe Tarantino, Christine G Lian, David R Liu, Rizwan Haq, Frank Stephen Hodi, Donald P Lawrence, Anita Giobbie-Hurder, Deborah Knoerzer, Ryan J Sullivan
A Phase II study of ERK inhibition by ulixertinib (BVD-523) in Metastatic Uveal Melanoma. Cancer research communications (2024)
Glenn J Hanna, Harita Dharanesswaran, Anita Giobbie-Hurder, John J Harran, Zixi Liao, Lori Pai, Vatche Tchekmedyian, Emily S Ruiz, Abigail H Waldman, Chrysalyne D Schmults, Leonardo V Riella, Patrick H Lizotte, Cloud P Paweletz, Anil K Chandraker, Naoka Murakami, Ann W Silk
Cemiplimab for Kidney Transplant Recipients With Advanced Cutaneous Squamous Cell Carcinoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (9) (2024)
Elizabeth I Buchbinder, Justine V Cohen, Giuseppe Tarantino, Christine G Lian, David R Liu, Rizwan Haq, Frank Stephen Hodi, Donald P Lawrence, Anita Giobbie-Hurder, Deborah Knoerzer, Ryan J Sullivan
A Phase II Study of ERK Inhibition by Ulixertinib (BVD-523) in Metastatic Uveal Melanoma. Cancer research communications 4 (5) (2024)
Glenn J Hanna, Harita Dharanesswaran, Anita Giobbie-Hurder, John J Harran, Zixi Liao, Lori Pai, Vatche Tchekmedyian, Emily S Ruiz, Abigail H Waldman, Chrysalyne D Schmults, Leonardo V Riella, Patrick H Lizotte, Cloud P Paweletz, Anil K Chandraker, Naoka Murakami, Ann W Silk
Cemiplimab for Kidney Transplant Recipients With Advanced Cutaneous Squamous Cell Carcinoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (9) (2024)
Glenn J Hanna, Harita Dharanesswaran, Anita Giobbie-Hurder, John J Harran, Zixi Liao, Lori Pai, Vatche Tchekmedyian, Emily S Ruiz, Abigail H Waldman, Chrysalyne D Schmults, Leonardo V Riella, Patrick H Lizotte, Cloud P Paweletz, Anil K Chandraker, Naoka Murakami, Ann W Silk
Cemiplimab for Kidney Transplant Recipients With Advanced Cutaneous Squamous Cell Carcinoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
K Ina Ly, Leland G K Richardson, Mofei Liu, Alona Muzikansky, Jonathan Cardona, Kevin Lou, Andrew L Beers, Ken Chang, James M Brown, Xiaoyue Ma, David A Reardon, Isabel C Arrillaga-Romany, Deborah A Forst, Justin T Jordan, Eudocia Quant Lee, Jorg Dietrich, Lakshmi Nayak, Patrick Yung Wen, Ugonma N Chukwueke, Anita Giobbie-Hurder, Bryan D Choi, Tracy T Batchelor, Jayashree Kalpathy-Cramer, William T Curry, Elizabeth R Gerstner
Bavituximab decreases immunosuppressive myeloid-derived suppressor cells in newly diagnosed glioblastoma patients. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Saba Tabasum, Dinesh Thapa, Anita Giobbie-Hurder, Jason L Weirather, Marco Campisi, Pieter J Schol, Xiaoyu Li, Jingjing Li, Charles H Yoon, Michael P Manos, David A Barbie, Frank Stephen Hodi
EDIL3 as an angiogenic target of immune exclusion following checkpoint blockade. Cancer immunology research (2023)
Xiaoyu Li, Jingjing Li, Yue Zheng, Sandra J Lee, Jun Zhou, Anita Giobbie-Hurder, Lisa H Butterfield, Glenn Dranoff, Frank Stephen Hodi
Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) Influence on Soluble and Membrane Bound ICOS in Combination with Immune Checkpoint Blockade. Cancer immunology research (2023)
Kyle Wright, Jason L Weirather, Sizun J Jiang, Katrina Z Kao, Yaron M Sigal, Anita Giobbie-Hurder, Margaret A Shipp, Scott J Rodig
Diffuse Large B-cell Lymphomas Have Spatially-Defined Tumor-Immune Microenvironments Revealed by High-Parameter Imaging. Blood advances (2023)
Priscilla Kaliopi Brastianos, Albert E Kim, Anita Giobbie-Hurder, Eudocia Q Lee, Nancy U Lin, Beth A Overmoyer, Patrick Y Wen, Lakshmi Nayak, Justine V Cohen, Jorg Dietrich, April Eichler, Rebecca S Heist, Ian Krop, Donald Lawrence, Jennifer Ligibel, Sara M Tolaney, Erica L Mayer, Eric Winer, Brittany Bent, Magali A de Sauvage, Nazanin Ijad, Juliana M Larson, Braxton Marion, Sally Nason, Naina Murthy, Sherry Ratcliff, Elizabeth J Summers, Maura Mahar, Helen A Shih, Kevin Oh, Daniel P Cahill, Elizabeth R Gerstner, Ryan J Sullivan
Pembrolizumab in brain metastases of diverse histologies: phase 2 trial results. Nature medicine (2023)
Foluso O Ademuyiwa, Feng Gao, Cherease R Street, Ina Chen, Donald W Northfelt, Robert Wesolowski, Mili Arora, Adam M Brufsky, E Claire Dees, Cesar A Santa-Maria, Caitriona Cahir, Jeremy Force, Alvaro Moreno-Aspitia, John M Herndon, Madelyn Carmody, Sherri R Davies, Sarah Larson, Kathleen L Pfaff, Stephanie M Jones, Jason L Weirather, Anita Giobbie-Hurder, Scott J Rodig, Zheng Liu, Ian S Hagemann, Elad Sharon, William E Gillanders
A randomized phase 2 study of neoadjuvant carboplatin and paclitaxel with or without atezolizumab in triple negative breast cancer (TNBC) - NCI 10013. NPJ breast cancer 8 (1) (2022)
Priscilla Kaliopi Brastianos, Albert E Kim, Anita Giobbie-Hurder, Eudocia Quant Lee, Nancy Wang, April F Eichler, Ugonma Chukwueke, Deborah A Forst, Isabel C Arrillaga-Romany, Jorg Dietrich, Zachary A Corbin, Jennifer Moliterno, Joachim Baehring, Michael White, Kevin W Lou, Juliana Larson, Magali A de Sauvage, Kathryn Evancic, Joana Liliana Mora, Naema Nayyar, Jay Loeffler, Kevin Oh, Helen A Shih, William T Curry, Daniel P Cahill, Fred G Barker, Elizabeth R Gerstner, Sandro Santagata
Phase 2 study of pembrolizumab in patients with recurrent and residual high-grade meningiomas. Nature communications 13 (1) (2022)
Foluso O Ademuyiwa, Feng Gao, Cherease R Street, Ina Chen, Donald W Northfelt, Robert Wesolowski, Mili Arora, Adam M Brufsky, E Claire Dees, Cesar A Santa-Maria, Caitriona Cahir, Jeremy Force, Alvaro Moreno-Aspitia, John M Herndon, Madelyn Carmody, Sherri R Davies, Sarah Larson, Kathleen L Pfaff, Stephanie M Jones, Jason L Weirather, Anita Giobbie-Hurder, Scott J Rodig, Zheng Liu, Ian S Hagemann, Elad Sharon, William E Gillanders
A randomized phase 2 study of neoadjuvant carboplatin and paclitaxel with or without atezolizumab in triple negative breast cancer (TNBC) - NCI 10013. NPJ breast cancer 8 (1) (2022)
Foluso O Ademuyiwa, Feng Gao, Cherease R Street, Ina Chen, Donald W Northfelt, Robert Wesolowski, Mili Arora, Adam M Brufsky, E Claire Dees, Cesar A Santa-Maria, Caitriona Cahir, Jeremy Force, Alvaro Moreno-Aspitia, John M Herndon, Madelyn Carmody, Sherri R Davies, Sarah Larson, Kathleen L Pfaff, Stephanie M Jones, Jason L Weirather, Anita Giobbie-Hurder, Scott J Rodig, Zheng Liu, Ian S Hagemann, Elad Sharon, William E Gillanders
A randomized phase 2 study of neoadjuvant carboplatin and paclitaxel with or without atezolizumab in triple negative breast cancer (TNBC) - NCI 10013. NPJ breast cancer 8 (1) (2022)
Joshua K Sabari, Vamsidhar Velcheti, Kazuhide Shimizu, Matthew R Strickland, Rebecca S Heist, Mohini Singh, Naema Nayyar, Anita Giobbie-Hurder, Subba R Digumarthy, Justin F Gainor, Anant P Rajan, Edwin Nieblas-Bedolla, Aaron C Burns, Jill Hallin, Peter Olson, James G Christensen, Sylvia C Kurz, Priscilla Kaliopi Brastianos, Hiroaki Wakimoto
Activity of Adagrasib (MRTX849) in Brain Metastases: Preclinical Models and Clinical Data from Patients with KRASG12C-Mutant Non-Small Cell Lung Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 28 (15) (2022)
Foluso O Ademuyiwa, Feng Gao, Cherease R Street, Ina Chen, Donald W Northfelt, Robert Wesolowski, Mili Arora, Adam M Brufsky, E Claire Dees, Cesar A Santa-Maria, Caitriona Cahir, Jeremy Force, Alvaro Moreno-Aspitia, John M Herndon, Madelyn Carmody, Sherri R Davies, Sarah Larson, Kathleen L Pfaff, Stephanie M Jones, Jason L Weirather, Anita Giobbie-Hurder, Scott J Rodig, Zheng Liu, Ian S Hagemann, Elad Sharon, William E Gillanders
A randomized phase 2 study of neoadjuvant carboplatin and paclitaxel with or without atezolizumab in triple negative breast cancer (TNBC) - NCI 10013. NPJ breast cancer 8 (1) (2022)
Tanya E Keenan, Jennifer L Guerriero, Romualdo Barroso-Sousa, Tianyu Li, Tess A O'Meara, Anita Giobbie-Hurder, Nabihah Tayob, Jiani Hu, Mariano Severgnini, Judith Agudo, Ines Vaz-Luis, Leilani Anderson, Victoria Attaya, Jihye Park, Jake Conway, Meng Xiao He, Brendan Reardon, Erin Shannon, Gerburg M Wulf, Laura M Spring, Rinath Jeselsohn, Ian Krop, Nancy U Lin, Ann Partridge, Eric P Winer, Elizabeth A Mittendorf, David Liu, Eliezer Van Allen, Sara M Tolaney
Molecular correlates of response to eribulin and pembrolizumab in hormone receptor-positive metastatic breast cancer. Nature communications 12 (1) (2021)